Code · BILL · 115th Congress · H.R. 2430 (Placed on Calendar Senate) — To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs,... · Sec. 404

Sec. 404. Reauthorization; reporting requirements

84 words·~1 min read·/bill/115/hr/2430/pcs/section-404

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

Section 744I of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 379j–53 ) is amended— in subsection (a)— by striking 2013 and inserting 2018 ; and by striking Biosimilar User Fee Act of 2012 and inserting ; Biosimilar User Fee Amendments of 2017 in subsection (b), by striking 2013 and inserting 2018 ; by striking subsection (d); by redesignating subsection

(e)as subsection (d); and in subsection (d), as so redesignated, by striking 2017 each place it appears and inserting 2022 .

Connections1 off-index

1 reference not yet in our index

21 USC 379j–53

Citation graph

cites case law

Sec. 404

Reauthorization; reporting requirements

Cite21 USC 379j–53

Cites 1Cited by 0 across 0 sources